Ortoma AB OMXSTO:ORT_B:
REGULATORY WIN IN AUSTRALIA FOR OTS HIP
Ortoma: Regulatory Win In Australia For OTS Hip
Earlier from Ortoma
- Ortoma Preliminary 2025 Operating Revenues At SEK 67 Mln
- Ortoma Q3 Net Sales Amounted To SEK 2.4 Million
- Ortoma Receives Orders From Japan
- Ortoma AB: Quarterly Trading Report 2025 Q3
- ORT_B: FDA approval and milestone payment fueled record sales and profit growth in H1 2025
Later from Ortoma
- ORT_B: 2025 revenue grew to 64.6 MSEK, but net loss deepened to -19.2 MSEK amid commercialization efforts
- Ortoma Announces Rights Issue Of SEK 52 Mln
- Ortoma publishes information document regarding the rights issue
- Ortoma Gets Regulatory Registration In UK, Milestone Compensation
- The subscription period in Ortoma’s rights issue begins today
Follow Ortoma into a list and get an email when it puts out news.
Follow Ortoma